About the new and improved Hot Tort Report
Being industry experts, we pride ourselves on keeping our finger on the pulse of all things Multi District Litigation. This predominantly consists of providing our subscribers with competitive insights into where the money is being spent in hopes of informing your blueprint for advertising strategies. These cases can be highly lucrative, but are difficult to acquire, requiring significant investment and patience to secure high-value cases.
We’ve been working hard on an algorithm to deliver more than just monthly TV spends and are proud to announce that we are ready to unveil our HTR 2.0.
This new list offers an overview of dollars spent across TV, Meta, PPC, and more, assigning a score to each tort based on what we, as leaders in the law firm advertising space, are witnessing across these various platforms.
The Hot Tort Report:
April 2026
The Hottest in Mass Tort Spending: March 2026
Social Media Addiction
Featured Tort
Subscribe to the Hot Tort Report
What’s the Tort News?
Published: April, 2026. Advertising spend from multiple sources for a recent 30 day period.
If you have any questions, please contact us at national@whitehardt.com
#1 Social Media Addiction
Social Media Addiction surged to the top of the rankings this month, climbing 3.3 points to keep its #1 position. The movement was driven by strong Meta activity alongside major courtroom developments and widespread media attention.
A landmark bellwether trial in Los Angeles has already delivered a major verdict against Meta and YouTube. This is expected to set a precedent for hundreds of similar cases moving forward and has significantly intensified scrutiny on the industry.
The world is watching to see how this groundbreaking mass tort continues to play out.
CPA: $782
CPL: $391
For common criteria, please contact us.
#2 Diabetes Meds for Weight Loss
Diabetes Meds for Weight Loss climbs to number two this month, rising from fourth with a 2.1-point increase. The growth was driven by gains in both WHii and TV activity, while Meta remained maxed out and PPC held steady. In a largely digital report, this added TV presence continues to set this tort apart.
The increase in WHii signals growing visibility across both media coverage and litigation activity, reinforcing that this is not just an advertising-driven rise. With momentum building across multiple channels, Diabetes Meds for Weight Loss continues to solidify its position as a leading and closely watched tort.
CPA: $91 – $463
CPL: $68 – $347
Common Criteria: Took a prescription diabetes drug for weight loss (e.g. Ozempic®, Mounjaro®), discontinued use of the drug, and experienced one or more gastrointestinal disorders at least 30 days after your first dose.
#3 Roblox Child Abuse
The Roblox Child Abuse mass tort moved from #6 to #3 this month, gaining 1.1 points overall. The increase was driven primarily by a rise in TV activity, making it one of the few torts this month to benefit from broadcast alongside digital support. Meta remains maxed out, with PPC steady.
State-level involvement continues to expand. Nebraska has now joined other states in filing suit against Roblox, adding to growing scrutiny around platform safety and child protection. With both advertising diversification and increasing government action, this tort continues to build momentum near the top of the rankings.
If you’re looking to capitalize on this momentum, Whitehardt can help position your firm to compete and scale effectively.
For metrics such as CPA, CPL, and common criteria, please contact us.
#4 Roundup®
After falling just outside the top ten last month, Roundup® returns in a strong position at #4. Digital activity remains the primary driver, with Meta maxed out and steady PPC support, while WHii signals have strengthened, reflecting increased attention across both litigation and media.
A high-stakes Supreme Court case set for April 27th will determine whether thousands of state-level failure-to-warn claims can proceed. Recent filings, including a new amicus brief supporting plaintiffs, highlight the broader legal and political stakes surrounding the litigation.
With both settlement activity ongoing and a major court decision on the horizon, Roundup® is reentering the rankings with renewed momentum and remains one of the most closely watched torts right now.
CPA: $1,238
CPL: $743
For common criteria, please contact us.
#5 Rideshare Assault
Rideshare Assault holds the same total score this month but slips to #5 as competition at the top intensifies. The campaign remains strongly digital, with Meta maxed out and PPC continuing to provide meaningful support, while TV activity remains absent.
A new MDL structure is being formalized in federal court, with leadership appointed and early case management deadlines now in place, signaling that the litigation is moving into a more organized and accelerated phase.
While the score held steady, the drop in rank reflects just how tight the top tier has become. With litigation progressing and structure solidifying, this tort remains firmly in the competitive mix.
For metrics such as CPA, CPL, and common criteria, please contact us.
#6 Talcum Powder
Talcum Powder steps up one rung in the ladder to #6 this month, gaining both position and momentum in a tightly packed report. Digital activity remains strong, with Meta maxed out and steady PPC support continuing to drive performance.
On the litigation side, developments have added a new layer of complexity. A federal judge recently disqualified a major plaintiffs’ firm representing thousands of claimants, a move that could delay proceedings and reshape leadership across the litigation.
Even with that disruption, Talcum Powder remains firmly in the mix. As trials continue and the legal landscape evolves, this is a tort where momentum can shift quickly from month to month.
CPA: $940
CPL: $470
For common criteria, please contact us.
#7 Paraquat
Paraquat lands at #7 this month, gaining slightly overall but slipping three positions as the field tightened around it. Like much of the top ten, Paraquat remains heavily digital, with Meta doing most of the work and PPC providing steady support. TV remains inactive.
In a report this compressed, incremental gains were not enough to move it higher. Despite a stronger score, Paraquat remains firmly in the mix rather than advancing up the rankings.
CPA: $711
CPL: $320
Common Criteria: Diagnosis of Parkinson’s Disease or experiencing Parkinson’s-like symptoms after exposure to Paraquat.
#8 Birth Control Injections
Birth Control Injections drops to #8 this month, falling from second as the top tier tightened. Meta and PPC were at their max, and there was no TV presence. This continues to be a fully digital campaign. This is less about fading momentum and more about how competitive the top ten has become. Even with a slight drop in score, Birth Control Injections is a closely watched tort.
CPA: $5,169
CPL: $3,050
For common criteria, please contact us.
#9 Takata Airbag Recall
Takata Airbag Recall lands at #9 this month, moving up one position with a slight increase in WHii. This remains the most TV-driven campaign in the report, with broadcast activity continuing to do the heavy lifting, while Meta and PPC provide limited support. Beyond that, this is a steady, ongoing tort. Activity remains consistent, but without a major shift this month, movement in the rankings is more reflective of changes around it than within it.
For metrics such as CPA, CPL, and common criteria, please contact us.
#10 Video Game Addiction
The Video Game Addiction campaign remains firmly digital, with Meta still maxed out and PPC providing consistent support. WHii remains moderate, reflecting steady but not accelerating activity across media and litigation.
In a tightly packed report, even small shifts matter. While this tort remains active and relevant, it fell a spot instead of holding steady. Will it be ablt to stay in the top ten next month?
Common Criteria: Child must be under 18 and spend 4+ hours per day, 5+ days per week, playing Minecraft, Fortnite, GTA 5, or Call of Duty. Child must also experience one or more of the following: addiction, poor school performance, school dropout, cognitive or developmental delays, chronic depression or anxiety, or self-harm/suicidal behavior.
For metrics such as CPA and CPL, please contact us.
Mesothelioma
You may be noticing a tort missing from our new report. While Mesothelioma continues to dominate the competition when it comes to spend levels, Whitehardt finds that this tort is its own niche animal. These cases can be extremely fruitful, but hard to come by, requiring a high buy-in to get in the game and patience when landing that ringer of a case. We believe that Meso will remain a constant for some time, but in regards to many of the other drugs and devices we focus on in this monthly report, we’ve decided to move it to its own category. If you are interested in hearing the latest news on Meso or how Whitehardt may be currently seeking these cases, you can contact us here.
Whitehardt will continue to track meso spending from month to month, so if you are interested in ongoing meso spending, please reach out to us directly. Going forward, we will be excluding meso from these tort reports.